Evidence map›Paper›PMID 33627405›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

T cells selectively filter oscillatory signals on the minutes timescale.

Geoff P O'Donoghue, Lukasz J Bugaj, Warren Anderson, Kyle G Daniels, David J Rawlings, Wendell A Lim

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Coupling Recombinant PhyB to Cell Culture Plates and Beads.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  9. Review
  10. Optogenetic engineering for precision cancer immunotherapy.Trends in pharmacological sciences · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Significant Advancements and Evolutions in Chimeric Antigen Receptor Design.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Geoff P O'DonoghueHHMI, University of California, San Francisco, CA 94158.
Lukasz J BugajHHMI, University of California, San Francisco, CA 94158.ORCID 0000-0002-0749-2912
Warren AndersonCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101.ORCID 0000-0002-9315-5233
Kyle G DanielsHHMI, University of California, San Francisco, CA 94158.
David J RawlingsCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101.ORCID 0000-0002-0810-1776
Wendell A LimHHMI, University of California, San Francisco, CA 94158; wendell.lim@ucsf.edu.
University of California, San Francisco · USUniversity of Washington · US

Funding

Redesigning the T cell: Using Synthetic Biology to Engineer Therapeutic CellsR01CA196277 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIM, WENDELL A · 2014 to 2018
$3.3M
Optogenetic dissection of the growth and activation network in T cellsF32GM116489 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI O'DONOGHUE, GEOFFREY · 2015 to 2016
$115k
Howard Hughes Medical InstituteNCI NIH HHS R01 CA196277NIGMS NIH HHS F32 GM116489
6 · The paper itself

Abstract

T cells experience complex temporal patterns of stimulus via receptor-ligand-binding interactions with surrounding cells. From these temporal patterns, T cells are able to pick out antigenic signals while establishing self-tolerance. Although features such as duration of antigen binding have been examined, our understanding of how T cells interpret signals with different frequencies or temporal stimulation patterns is relatively unexplored. We engineered T cells to respond to light as a stimulus by building an optogenetically controlled chimeric antigen receptor (optoCAR). We discovered that T cells respond to minute-scale oscillations of activation signal by stimulating optoCAR T cells with tunable pulse trains of light. Systematically scanning signal oscillation period from 1 to 150 min revealed that expression of CD69, a T cell activation marker, reached a local minimum at a period of ∼25 min (corresponding to 5 to 15 min pulse widths). A combination of inhibitors and genetic knockouts suggest that this frequency filtering mechanism lies downstream of the Erk signaling branch of the T cell response network and may involve a negative feedback loop that diminishes Erk activity. The timescale of CD69 filtering corresponds with the duration of T cell encounters with self-peptide-presenting APCs observed via intravital imaging in mice, indicating a potential functional role for temporal filtering in vivo. This study illustrates that the T cell signaling machinery is tuned to temporally filter and interpret time-variant input signals in discriminatory ways.

Indexed as

Self ToleranceAnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteBrefeldin ACD69 AntigensCell EngineeringFeedback, PhysiologicalGene Expression RegulationHepatitis A Virus Cellular Receptor 2HumansInterferon-gammaK562 CellsLectins, C-TypeLightLight Signal TransductionAntigens, CDAntigens, Differentiation, T-LymphocyteBrefeldin ACD69 AntigensHAVCR2 protein, humanHepatitis A Virus Cellular Receptor 2IFNG protein, humanInterferon-gammaLectins, C-TypeMAPK1 protein, humanMAPK3 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3MonensinProtein Tyrosine Phosphatase, Non-Receptor Type 22PTPN22 protein, humanReceptors, Chimeric Antigencell signalingoptogeneticssignal transductionsynthetic biology

Identifiers

PMID33627405
PMCPMC7936380
OpenAlexW3131662068

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.